Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Fluicell

13.50 SEK

-3.57 %

Less than 1K followers

FLUI

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Fluicell

2019202020212022202320242025
Revenue2.54.62.63.33.31.96.0
growth-%86.3 %-43.9 %24.9 %2.8 %-44.3 %222.7 %
EBITDA-18.2-16.4-21.1-21.0-26.3-15.4-8.0
EBIT-18.7-17.0-21.7-21.7-26.9-15.8-8.4
Profit before taxes-18.6-17.6-21.7-21.6-26.6-15.5-8.3
Net income-18.6-17.6-21.7-21.6-26.6-15.5-8.3
EPS-181.40-111.83-118.62-71.63-79.77-10.50-6.07
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-729.9 %-354.3 %-811.2 %-646.5 %-786.5 %-828.0 %-133.7 %
EBIT-%-750.9 %-367.3 %-833.8 %-668.6 %-804.8 %-851.6 %-139.9 %
ROE-182.2 %-90.2 %-113.5 %-92.2 %-6,174.4 %-80.7 %-76.4 %
ROI-93.5 %-70.8 %-80.4 %-68.0 %-284.3 %-60.8 %-45.1 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.